SEC Form 4 · accession 0001179110-18-014063
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Timney
Officer — Chief Executive Officer · Director
Period of report
Dec 10, 2018
Accepted (ET)
Dec 18, 2018 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 17, 2018 | P | 26,863 | $18.60 | A | 26,863 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F2 | $20.79 | Dec 10, 2018 | A | 450,000 | A | — | Dec 10, 2028 | Common Stock | 450,000 | 450,000 | D |
Explanation of responses
- F1Represents the weighted average purchase price of the shares purchased ranging from a low of $17.87 to a high of $19.17 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- F2This option vests 25% on December 10, 2019 and in thirty-six equal monthly installments thereafter.